• Could Savient Pharmaceuticals, Inc. (SVNT) Really be Bankrupt? More...
• Pfizer Inc. (PFE) Pays $450 Million to Brigham Young University Over Celebrex Spat More...
• Novaliq Receives E3.9 Million in Further Round of Financing Talks More...
• Pfizer Inc. (PFE) Races to Reinvent Itself, Hunts for Mid-size Drug DealsMore...
• Synexus Further Strengthens Its Presence in Poland with the Acquisition of Osteomed More...
• Axerion Therapeutics, AstraZeneca PLC (AZN) Inks Pact to Combat Alzheimer's Disease More...
• Gentium S.p.A. Appoints PharmaSwiss, S.A. as Exclusive Distributor of Defibrotide in Central and Eastern European Countries More...
• Evotec AG (EVTG.F) Grants Exclusive Rights on EVT 401 in China to Conba Pharmaceutical More...
• Nanobiotix and Thomas Jefferson University Start Research Collaboration More...
• Trevena, Inc. Enters Research Collaboration with Merck & Co., Inc. (MRK) To Identify Novel Biased Ligand Molecules More...
• Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer More...
• Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland More...
• Althea Technologies, Inc. Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing More...
• Kevin C. O'Boyle Joins Durata Therapeutics, Inc. ' Board of Directors More...
• Knopp Biosciences Announces Recruiting of Key Scientific Executives and Completion of Laboratory Expansion More...
• Acura Pharmaceuticals, Inc. (ACUR) Announces First Quarter 2012 Financial Results More...
• Agennix AG Schedules Conference Call on May 9 to Discuss First Quarter 2012 Financial Results More...
• Amarin Corporation PLC (AMRN) to Report First Quarter 2012 Financial Results and Host Conference Call on May 8, 2012 More...
• AMAG Pharmaceuticals, Inc. (AMAG) Announces First Quarter 2012 Financial Results More...
• Arena Pharmaceuticals, Inc. (ARNA) Announces First Quarter 2012 Financial Results and Recent Developments More...
• Eli Lilly and Company (LLY) Invests in UK Research Base More...
• AVEO Pharmaceuticals, Inc. (AVEO) Lung Cancer Drug Fails Phase II Study More...
• Novartis AG (NVS) Drug for Smoker's Cough Boosts Lung Function in Study More...
• Novo Nordisk A/S (NVO) Says Blood Drugs Could Hold Blockbuster Potential More...
• Gilead Sciences, Inc. (GILD) Initiates Phase 3 Clinical Trial Evaluating GS-1101 for the Treatment of Chronic Lymphocytic Leukemia More...
• NovaBay Pharmaceuticals, Inc.'s Aganocide Out-Performed Traditional Antibiotics in Drug Resistance Study More...
• Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX) Wins FDA Nod for Gaucher Disease Drug; Genzyme Corporation (GENZ) Faces Competition More...
• MEDA's Dymista Approved by the FDA More...
• Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution More...
• Zogenix, Inc. Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro(TM) for Treatment of Chronic Pain More...
• Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism More...
• A Woman's Intense Interest in Her Partner Shifts When Grandchildren Arrive,University of Oxford Study More...
• Fish Oil Doesn't Cut Failure Rate of Hemodialysis Grafts, Lawson Health Research Institute Study More...
• Computer Use and Exercise Combo May Reduce the Odds of Having Memory Loss, Mayo Clinic Study More...
• Vitamin D Blood Level for Reducing Major Medical Risks in Older Adults Identified, University of Washington Study More...
• Advanced Cell Technology Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration Using Human Embryonic Stem Cell-Derived RPE Cells More...
• Biodel Inc. (BIOD)'s Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office More...
• Entia Biosciences Launches Medical Food for Treatment of Rheumatoid Arthritis More...
• Bioniche Life Sciences Inc. (BNC) Commercializing Two Products for Canine Cancer More...
• Pfizer Inc. (PFE) Pays $450 Million to Brigham Young University Over Celebrex Spat More...
• Novaliq Receives E3.9 Million in Further Round of Financing Talks More...
• Pfizer Inc. (PFE) Races to Reinvent Itself, Hunts for Mid-size Drug DealsMore...
• Synexus Further Strengthens Its Presence in Poland with the Acquisition of Osteomed More...
• Axerion Therapeutics, AstraZeneca PLC (AZN) Inks Pact to Combat Alzheimer's Disease More...
• Gentium S.p.A. Appoints PharmaSwiss, S.A. as Exclusive Distributor of Defibrotide in Central and Eastern European Countries More...
• Evotec AG (EVTG.F) Grants Exclusive Rights on EVT 401 in China to Conba Pharmaceutical More...
• Nanobiotix and Thomas Jefferson University Start Research Collaboration More...
• Trevena, Inc. Enters Research Collaboration with Merck & Co., Inc. (MRK) To Identify Novel Biased Ligand Molecules More...
• Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer More...
• Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland More...
• Althea Technologies, Inc. Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing More...
• Kevin C. O'Boyle Joins Durata Therapeutics, Inc. ' Board of Directors More...
• Knopp Biosciences Announces Recruiting of Key Scientific Executives and Completion of Laboratory Expansion More...
• Acura Pharmaceuticals, Inc. (ACUR) Announces First Quarter 2012 Financial Results More...
• Agennix AG Schedules Conference Call on May 9 to Discuss First Quarter 2012 Financial Results More...
• Amarin Corporation PLC (AMRN) to Report First Quarter 2012 Financial Results and Host Conference Call on May 8, 2012 More...
• AMAG Pharmaceuticals, Inc. (AMAG) Announces First Quarter 2012 Financial Results More...
• Arena Pharmaceuticals, Inc. (ARNA) Announces First Quarter 2012 Financial Results and Recent Developments More...
• Eli Lilly and Company (LLY) Invests in UK Research Base More...
• AVEO Pharmaceuticals, Inc. (AVEO) Lung Cancer Drug Fails Phase II Study More...
• Novartis AG (NVS) Drug for Smoker's Cough Boosts Lung Function in Study More...
• Novo Nordisk A/S (NVO) Says Blood Drugs Could Hold Blockbuster Potential More...
• Gilead Sciences, Inc. (GILD) Initiates Phase 3 Clinical Trial Evaluating GS-1101 for the Treatment of Chronic Lymphocytic Leukemia More...
• NovaBay Pharmaceuticals, Inc.'s Aganocide Out-Performed Traditional Antibiotics in Drug Resistance Study More...
• Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX) Wins FDA Nod for Gaucher Disease Drug; Genzyme Corporation (GENZ) Faces Competition More...
• MEDA's Dymista Approved by the FDA More...
• Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution More...
• Zogenix, Inc. Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro(TM) for Treatment of Chronic Pain More...
• Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism More...
• A Woman's Intense Interest in Her Partner Shifts When Grandchildren Arrive,University of Oxford Study More...
• Fish Oil Doesn't Cut Failure Rate of Hemodialysis Grafts, Lawson Health Research Institute Study More...
• Computer Use and Exercise Combo May Reduce the Odds of Having Memory Loss, Mayo Clinic Study More...
• Vitamin D Blood Level for Reducing Major Medical Risks in Older Adults Identified, University of Washington Study More...
• Advanced Cell Technology Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration Using Human Embryonic Stem Cell-Derived RPE Cells More...
• Biodel Inc. (BIOD)'s Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office More...
• Entia Biosciences Launches Medical Food for Treatment of Rheumatoid Arthritis More...
• Bioniche Life Sciences Inc. (BNC) Commercializing Two Products for Canine Cancer More...
0 comments